Improved Long-Term Survival with Edaravone Therapy in Patients with Amyotrophic Lateral Sclerosis: A Retrospective Single-Center Study in Japan

Reports on the long-term survival effect of edaravone, which was approved for the treatment of amyotrophic lateral sclerosis (ALS) in 2015 in Japan, are rare. Herein, we report our retrospective analysis of 45 consecutive patients with ALS who initially visited our hospital between 2013 and 2018. Of...

Descripción completa

Detalles Bibliográficos
Autores principales: Houzen, Hideki, Kano, Takahiro, Horiuchi, Kazuhiro, Wakita, Masahiro, Nagai, Azusa, Yabe, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398196/
https://www.ncbi.nlm.nih.gov/pubmed/34451802
http://dx.doi.org/10.3390/ph14080705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398196/
https://www.ncbi.nlm.nih.gov/pubmed/34451802
http://dx.doi.org/10.3390/ph14080705

Ejemplares similares